NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-101-2012-1-ZA-20 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS ZA National Stage 2016/00064 Pending
NINDS E-101-2012-1-SG-18 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS SG National Stage 11201510764Q Pending
NINDS E-101-2012-1-PE-17 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS PE National Stage 000010-2016 Pending
NCATS E-243-2014-0-CA-04 Mutant IDH1 Inhibitors Useful for Treating Cancer CA National Stage 2971872 Issued
NICHD E-039-2015-0-CA-03 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof CA National Stage 2972038 Issued
NCATS E-243-2014-0-EP-06 Mutant IDH1 Inhibitors Useful for Treating Cancer EP National Stage 15823901.2 Issued
NCATS E-243-2014-0-GB-12 Mutant IDH1 Inhibitors Useful for Treating Cancer GB EP 15823901.2 Issued
NCATS E-243-2014-0-FR-11 Mutant IDH1 Inhibitors Useful for Treating Cancer FR EP 15823901.2 Issued
NCATS E-243-2014-0-DE-09 Mutant IDH1 Inhibitors Useful for Treating Cancer DE EP 15823901.2 Issued
NCATS E-243-2014-0-ES-10 Mutant IDH1 Inhibitors Useful for Treating Cancer ES EP 15823901.2 Issued
NCATS E-243-2014-0-IT-13 Mutant IDH1 Inhibitors Useful for Treating Cancer IT EP 15823901.2 Issued
NCATS E-243-2014-0-CN-05 Mutant IDH1 Inhibitors Useful for Treating Cancer CN National Stage 2015800763284 Issued
NICHD E-039-2015-0-CN-04 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof CN National Stage 201580076462.4 Issued
NCATS E-243-2014-0-AU-03 Mutant IDH1 Inhibitors Useful for Treating Cancer AU National Stage 2015369712 Issued
NICHD E-039-2015-0-BE-11 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof BE EP 15830932.8 Issued
NICHD E-039-2015-0-IT-17 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof IT EP 15830932.8 Issued
NICHD E-039-2015-0-CH-12 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof CH EP 15830932.8 Issued
NICHD E-039-2015-0-GB-16 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof GB EP 15830932.8 Issued
NICHD E-039-2015-0-EP-05 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof EP National Stage 15830932.8 Issued
NICHD E-039-2015-0-DE-13 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof DE EP 15830932.8 Issued
NICHD E-039-2015-0-FR-15 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof FR EP 15830932.8 Issued
NICHD E-039-2015-0-NL-18 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof NL EP 15830932.8 Issued
NICHD E-039-2015-0-SE-19 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof SE EP 15830932.8 Issued
NICHD E-039-2015-0-ES-14 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof ES EP 15830932.8 Issued
NCATS E-243-2014-0-US-08 MUTANT IDH1 INHIBITORS USEFUL FOR TREATING CANCER US National Stage 15/538,570 10703746 Issued PDF
NICHD E-039-2015-0-IL-06 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof IL National Stage 253103 Issued
NIAAA E-103-2013-0-US-04 Glucan-Encapsulated Sirna for Treating Type 2 Diabetes Mellitus US National Stage 14/900,951 10077446 Issued PDF
NCATS E-243-2014-0-PCT-02 Mutant IDH1 Inhibitors Useful for Treating Cancer PCT PCT PCT/US2015/067406 Expired
NICHD E-039-2015-0-PCT-02 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof PCT PCT PCT/US2015/067338 Expired
NICHD E-039-2015-0-JP-10 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof JP DIV 2019-220144 Abandoned
NCI E-283-2008-0-AU-10 Method For Detection Of Cancer Based On Spatial Genome Organization AU DIV 2015271909 Abandoned
CC E-228-2015-0-US-01 Automated Cancer Detection Using MRI US ORD 14/971,296 10215830 Issued PDF
NCI E-086-2015-0-EP-03 Bispecific Multivalent Fusion Proteins EP National Stage 15823452.6 Abandoned
NCI E-086-2015-0-PCT-02 Bispecific Multivalent Fusion Proteins PCT PCT PCT/US15/066131 Expired
NIAID E-120-2013-0-US-03 Cytolethal Distending Toxin Subunit B Conjugated or Fused to Bacillus Anthracis Toxin Lethal Factor US National Stage 14/898,248 9890369 Issued PDF
NHLBI E-115-2013-0-US-04 Encircling Implant Delivery Systems and Methods US National Stage 14/898,020 10463495 Issued PDF
NIBIB E-158-2015-0-US-01 Vesicle Containing Metallic Nanoparticle and Method for Production Thereof US 62/266,289 Abandoned
NIAID E-037-2016-0-US-01 RECOMBINANT RESPIRATORY SYNCTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS US 62/266,206 Abandoned
NIAID E-216-2014-0-US-01 Recombinant Respiratory Syncytial Virus (RSV) Strains with Mutations in the M2-2 ORF Providing A Range of Attenuation Phenotypes US 62/266,199 Abandoned
NHGRI E-275-2015-0-US-01 Gene Therapy For Cobalamin C Deficiency US 62/266,352 Abandoned
NCI E-351-2013-0-US-03 HER2-Specific Monoclonal Antibodies and Conjugates Thereof US National Stage 14/897,389 9738726 Issued PDF
NCI E-248-2016-0-NL-12 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer NL EP 15868296.3 Issued
NCI E-248-2016-0-IE-11 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer IE EP 15868296.3 Issued
NCI E-248-2016-0-CH-07 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer CH EP 15868296.3 Issued
NCI E-248-2016-0-GB-10 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer GB EP 15868296.3 Issued
NCI E-248-2016-0-EP-03 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer EP National Stage 15868296.3 Issued
NCI E-248-2016-0-BE-06 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer BE EP 15868296.3 Issued
NCI E-248-2016-0-DE-08 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer DE EP 15868296.3 Issued
NCI E-248-2016-0-FR-09 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer FR EP 15868296.3 Issued
NCI E-248-2016-0-PCT-02 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer PCT PCT PCT/US2015/064792 Expired